Announcement from the University of Exeter March 2017
With great sadness we announce that Professor Terry Wilkin, the Chief Investigator for adAPT, has died following a long illness.
Professor Wilkin graduated from St Andrew‘s University Medical School and received his MD on thyroid autoimmunity from the University of Dundee. He spent the next 15 years with the Wellcome Trust, first as European Travelling Fellow at the University of Montpellier in Southern France and then as Wellcome Senior Research Fellow/Senior Lecturer/Reader at the University of Southampton. He moved to the Chair of Medicine at Plymouth University’s new Postgraduate Medical School in 1993 and then became Professor of Endocrinology and Metabolism at the University of Exeter Medical School. He published the accelerator hypothesis in 2001, and from 2000-2013 directed the EarlyBird Study, a 12-year cohort study of the behaviour of insulin resistance in contemporary children which provides the backdrop to adAPT.
Professor Wilkin’s dedication to the adAPT and Earlybird projects, his expertise and international reputation came from his work on understanding the natural history of insulin resistance during contemporary childhood; he published extensively in this area and challenged current thinking.
Professor Wilkin’s wish, supported by his family, was for adAPT to continue and we remain fully committed to delivering the trial. There will be a further announcement about the role of Chief Investigator as soon as possible. In the meantime, work on the trial proceeds as planned, with Terry and his family in our thoughts.
The funders of adAPT, JDRF, have posted a tribute to Terry here.
20th April 2016 marks adAPT’s media launch
“New trial aims to prevent type 1 diabetes”
The adAPT trial was officially launched on the 20th April. 1916, when national and local media met the chief investigator, Professor Terry Wilkin, and the trial team in the children’s hospital at Ninewells, Dundee. Click here to read the press release. Here and here to read the case studies.
The event was reported on BBC Radio 4 news, and subsequently discussed at more length on the Today Programme. It also went out on local media, national TV, and over 50 international networks. The aim of the launch was to promote awareness – local and national. Awareness fuels recruitment, and there were more than 30 enquiries to this website by the end of the day.
Thinking of joining adAPT? – click here
A few words from Fred MacAulay…
20th March 2015 sees adAPT’s first investigator’s meeting
Held in Dunkeld, Perthshire, the meeting was attended by consultant diabetologists, research nurses, and diabetes nurses, statisticians, the trial steering committee, sponsor, funder and clinical trials unit. The aim was for team located throughout Scotland to meet each other, for the investigators to describe the study, and for the clinical trials unit to explain how it would unfold. It is anticipated that investigators’ meetings will be held annually once the study is underway.
Here’s a shot of us all standing out there on a freezing cold Scottish Friday in March!